Revolution Medicines, Inc. (RVMD)
NASDAQ·Healthcare·Biotechnology
$143.19
-0.57%
Mkt Cap $30.23B
Analyst Ratings
Buy
26
Hold
0
Sell
0
Price Target (31 analysts)
$124.36
Range $73.00 – $170.00
Implied Upside
-13.2%
Consensus $124.36 vs current $143.19